Pliant Therapeutics Is A Clinical Stagebiopharmaceutical Company Based In South San Franciscocaliforniathecompany Is Dedicated To Discovering And Developing Innovativetherapies For Fibrotic Diseaseswhich Aresignificant Contributors To Organ Dysfunctionpliant Specializes In Tissuespecific Integrin Modulation And Tgf I 1 Signaling Inhibition To Effectively Target Fibrosisparticularly In Conditions Likeidiopathic Pulmonary Fibrosisipfand Primary Sclerosing Cholangitispscpliant S Lead Productpln 74809Is An Oral Small Moleculedual Inhibitor Currently In Phaseiib Iii Trials For Ipf And Pschaving Received Fda Fast Track And Orphan Drug Designationsthecompany Is Also Advancing Pln 101095 And Pln 1474Which Arein Preclinical And Phasei Stagestargeting Additional Pathways For Various Fibrotic Conditionspliant Emphasizes A Patient Centric Approach And Collaborates With Partnersincluding Novartis Ag And Academic Institutionsto Enhanceits Research And Clinical Development Efforts
No conferences found for this company.
| Company Name | Pliant Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
